About Cyano Biotech
Cyano Biotech is a company based in Berlin (Germany) founded in 2004 was acquired by Simris Alg in August 2022. Cyano Biotech operates in a competitive market with competitors including Jazz Pharmaceuticals, GSK, C4 Therapeutics, Erasca and MiRagen, among others.
- Headquarter Berlin, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cyano Biotech Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$205.97 K (USD), Grant
Sep 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
Simris Alg
(Aug 25, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cyano Biotech
Investors in Cyano Biotech
Cyano Biotech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Simris Alg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Algae are cultivated, harvested, and processed into oils and products.
|
Locked | Locked | Locked |
Investor details for Cyano Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cyano Biotech
Investment portfolio details for Cyano Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cyano Biotech
Detailed financials for Cyano Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cyano Biotech Comparisons
Peer comparison for Cyano Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cyano Biotech
Cyano Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, GSK, C4 Therapeutics, Erasca and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Cyano Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cyano Biotech
Complete news archive for Cyano Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyano Biotech
Cyano Biotech was founded in 2004 and raised its 1st funding round 16 years after it was founded.
Cyano Biotech is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Cyano Biotech was founded in 2004 and is based in Berlin, Germany. Operations in the biotech sector focus on screening cyanobacteria to identify and characterize natural products. Two product lines have been developed: microcystins for potential antitumor use and microginins as ACE inhibitors. Services provided include strains cultivation, biomass growth, extraction, fractionation, and compound purification for clients.
Cyano Biotech's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Cyano Biotech has 2 investors. Key investors include European Union, and Simris Alg.